Microdosing aims to subtly influence brain circuits without triggering hallucinatory effects. While it may engage serotonin receptors, the therapeutic benefits could overlap with those provided by SSRIs. The conversation raises questions about the existence of non-psychedelic drugs that selectively activate serotonin receptors, ultimately expressing skepticism about their current availability in psychiatric medicine.
